Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study
Jessica W. Crothers(Vermont Oxford Network), Peter L. Moses(University of Vermont), Rebecca Wilcox(University of Vermont), Wing Fei Wong(OpenBiome), Karen A. Fortner(University of Vermont Medical Center), Le Thanh Tu Nguyen(Broad Institute), Ralph C. Budd(University of Vermont), Cheryl Collins(University of Vermont), Ryan J. Elliott(OpenBiome), Magen Phillips(University of Vermont Medical Center), Aaron Cohn(University of Vermont Medical Center), Zain Kassam(Finch Therapeutics (United States)), Gary M. Mawe(University of Vermont), Brigitte Lavoie(University of Vermont), Roxana del Río(University of Vermont), Eric J. Alm(Singapore-MIT Alliance for Research and Technology), Elaine Vo(Finch Therapeutics (United States)), Mark Smith(PAT Industries (United States)), Peter Callas(University of Vermont), Mario H Ruíz Vélez(University of Vermont Medical Center), Nathaniel D. Chu(Broad Institute)
Cited by 125
Related Papers
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
|Nature Biotechnology|2019|24.2k
A framework for human microbiome research
|Nature|2012|2.8k
Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets
|Nature Reviews Gastroenterology & Hepatology|2013|1.1k
Meta-analysis of gut microbiome studies identifies disease-specific and shared responses
|Nature Communications|2017|1k